You're viewing one of tens of thousands of real cases compiled on Many.dev. Each case demonstrates specific, tangible expertise.
But how do you find the company that possesses the exact skills and experience needed for your project? Forget generic filters!
Our unique AI system allows you to describe your project in your own words and instantly get a list of companies that have already successfully applied that precise expertise in similar projects.
Thomson Reuters' JPharm platform suffered from a lack of technical documentation, heterogeneous data sources causing manual data processing delays, and an outdated architecture that hindered scalability and maintenance. Previous vendor attempts at modernization failed due to coordination issues and insufficient technical expertise.
Global provider of pharmaceutical market tracking and collaboration solutions with operations in research, regulatory compliance, and drug development support
The modernized platform will enable real-time pharmaceutical data collaboration across global teams, reduce manual data processing time by 70%, and establish a foundation for AI-driven drug discovery integrations. The architecture overhaul will support 5-year scalability requirements while maintaining regulatory compliance and reducing technical debt by 60%.